Catalyst Wire Dossier Catalyst Wire Dossier

Clofarabine, Cytarabine and Mitoxantrone (CLAM)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Clofarabine, Cytarabine and Mitoxantrone (CLAM), covering 2022-10-06 to 2022-10-06. Get the full timeline:

Most recent: Clinical Trial Update: Clofarabine, Cytarabine and Mitoxantrone (CLAM) for Relapsed or Refractory AML [Phase 2]

See pricing